Page 1 of 1

Peripheral Arterial Disease (PAD) & EDCs

PostPosted: Thu May 11, 2017 12:52 pm
by vavec001
Descriptive Table of NHANES 1999-2004 for PAD and selected co-variates. Participants ≥ 40 years of age. Analysis was done with SAS 9.4

Re: Peripheral Arterial Disease (PAD) & EDCs

PostPosted: Thu May 11, 2017 5:52 pm
by vavec001
Table of Geometric Mean PCB levels (ng/g) by PAD status among participants ≥ 40 years of age, NHANES 1999-2004. Table is based on Limit of Detection (LOD).

Re: Peripheral Arterial Disease (PAD) & EDCs

PostPosted: Fri May 12, 2017 3:25 pm
by vavec001
Geometric Mean PCB levels (ng/g) by peripheral arterial disease status by age groups, NHANES 1999-2004

Re: Peripheral Arterial Disease (PAD) & EDCs

PostPosted: Wed Jun 14, 2017 11:25 am
by vavec001
Descriptive Statistics for PAD & selected covariates among participants ≥ 40 years of age with bisphenol A (BPA) measurements NHANES 2003-2004 using SAS 9.4

Re: Peripheral Arterial Disease (PAD) & EDCs

PostPosted: Fri Jun 30, 2017 2:30 pm
by vavec001
Estimated Odds Ratios for Peripheral arterial disease (PAD) and PCB exposure NHANES 1999 - 2004 using SAS 9.4. Broken down into three separate tables: Individual PCB congeners 1) < LOD to 50% & ≥ 50%; 2) < LOD to 50%, 50% to 75%, & ≥ 75%; and 3) dioxin-like & non-dioxin-like PCBs

Re: Peripheral Arterial Disease (PAD) & EDCs

PostPosted: Sat Jul 08, 2017 2:55 pm
by vavec001
Estimated Odds Ratios for Peripheral arterial disease (PAD) and phthalate metabolites and BPA using SAS 9.4. Broken down into two tables: Individual phthalate metabolites 1999 - 2004 and bisphenol A (BPA) NHANES 2003 - 2004